BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 31446799)

  • 1. Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth.
    Yang Y; Gomez-Sanchez CE; Jaquin D; Aristizabal Prada ET; Meyer LS; Knösel T; Schneider H; Beuschlein F; Reincke M; Williams TA
    Hypertension; 2019 Oct; 74(4):809-816. PubMed ID: 31446799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone-Producing Adenomas: Histopathology-Genotype Correlation and Identification of a Novel
    Tan GC; Negro G; Pinggera A; Tizen Laim NMS; Mohamed Rose I; Ceral J; Ryska A; Chin LK; Kamaruddin NA; Mohd Mokhtar N; A Jamal AR; Sukor N; Solar M; Striessnig J; Brown MJ; Azizan EA
    Hypertension; 2017 Jul; 70(1):129-136. PubMed ID: 28584016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma.
    De Sousa K; Boulkroun S; Baron S; Nanba K; Wack M; Rainey WE; Rocha A; Giscos-Douriez I; Meatchi T; Amar L; Travers S; Fernandes-Rosa FL; Zennaro MC
    Hypertension; 2020 Apr; 75(4):1034-1044. PubMed ID: 32114847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production.
    Hattangady NG; Karashima S; Yuan L; Ponce-Balbuena D; Jalife J; Gomez-Sanchez CE; Auchus RJ; Rainey WE; Else T
    J Mol Endocrinol; 2016 Jul; 57(1):1-11. PubMed ID: 27099398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Aldosteronism: Spatial Multiomics Mapping of Genotype-Dependent Heterogeneity and Tumor Expansion of Aldosterone-Producing Adenomas.
    Gong S; Sun N; Meyer LS; Tetti M; Koupourtidou C; Krebs S; Masserdotti G; Blum H; Rainey WE; Reincke M; Walch A; Williams TA
    Hypertension; 2023 Jul; 80(7):1555-1567. PubMed ID: 37125608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
    Monticone S; Castellano I; Versace K; Lucatello B; Veglio F; Gomez-Sanchez CE; Williams TA; Mulatero P
    Mol Cell Endocrinol; 2015 Aug; 411():146-54. PubMed ID: 25958045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
    Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations.
    Okamura T; Nakajima Y; Katano-Toki A; Horiguchi K; Matsumoto S; Yoshino S; Yamada E; Tomaru T; Ishii S; Saito T; Ozawa A; Shibusawa N; Satoh T; Okada S; Nagaoka R; Takada D; Horiguchi J; Oyama T; Yamada M
    Endocr J; 2017 Jan; 64(1):39-47. PubMed ID: 27681703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a mutated KCNJ5 gene, G387R, in unilateral primary aldosteronism.
    Chueh JS; Peng KY; Wu VC; Wang SM; Chan CK; Chen YM; Ke YY; Pan CY; Liao HW
    J Mol Endocrinol; 2021 Sep; 67(4):203-215. PubMed ID: 34463641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.
    Monticone S; Hattangady NG; Nishimoto K; Mantero F; Rubin B; Cicala MV; Pezzani R; Auchus RJ; Ghayee HK; Shibata H; Kurihara I; Williams TA; Giri JG; Bollag RJ; Edwards MA; Isales CM; Rainey WE
    J Clin Endocrinol Metab; 2012 Aug; 97(8):E1567-72. PubMed ID: 22628608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different Somatic Mutations in Multinodular Adrenals With Aldosterone-Producing Adenoma.
    Fernandes-Rosa FL; Giscos-Douriez I; Amar L; Gomez-Sanchez CE; Meatchi T; Boulkroun S; Zennaro MC
    Hypertension; 2015 Nov; 66(5):1014-22. PubMed ID: 26351028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
    Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
    Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism.
    Mulatero P; Tauber P; Zennaro MC; Monticone S; Lang K; Beuschlein F; Fischer E; Tizzani D; Pallauf A; Viola A; Amar L; Williams TA; Strom TM; Graf E; Bandulik S; Penton D; Plouin PF; Warth R; Allolio B; Jeunemaitre X; Veglio F; Reincke M
    Hypertension; 2012 Feb; 59(2):235-40. PubMed ID: 22203740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolides Blunt Aldosterone Biosynthesis: A Proof-of-Concept Study in
    Caroccia B; Prisco S; Seccia TM; Piazza M; Maiolino G; Rossi GP
    Hypertension; 2017 Dec; 70(6):1238-1242. PubMed ID: 28993452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.
    Oki K; Plonczynski MW; Luis Lam M; Gomez-Sanchez EP; Gomez-Sanchez CE
    Endocrinology; 2012 Apr; 153(4):1774-82. PubMed ID: 22315453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Heterogeneity in Aldosterone-Producing Adenomas.
    Nanba K; Chen AX; Omata K; Vinco M; Giordano TJ; Else T; Hammer GD; Tomlins SA; Rainey WE
    J Clin Endocrinol Metab; 2016 Mar; 101(3):999-1007. PubMed ID: 26765578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations.
    Nanba K; Omata K; Tomlins SA; Giordano TJ; Hammer GD; Rainey WE; Else T
    Eur J Endocrinol; 2016 Aug; 175(2):K1-6. PubMed ID: 27165862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas.
    Kitamoto T; Suematsu S; Matsuzawa Y; Saito J; Omura M; Nishikawa T
    J Atheroscler Thromb; 2015; 22(2):191-200. PubMed ID: 25253161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different cell compositions and a novel somatic
    Zhao L; Wan J; Wang Y; Yang W; Liang Q; Wang J; Jin P
    Front Endocrinol (Lausanne); 2023; 14():1068335. PubMed ID: 36960396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism.
    Ip JC; Pang TC; Pon CK; Zhao JT; Sywak MS; Gill AJ; Soon PS; Sidhu SB
    ANZ J Surg; 2015 Apr; 85(4):279-83. PubMed ID: 24274318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.